Alkermes (ALKS) Net Margin Growth (1y) (2011 - 2025)
Alkermes (ALKS) Net Margin Growth (1y) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 372.00 |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | -82.00 |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | -538.00 |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | -2,930.00 |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 2,292.00 |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | -146.00 |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 1,181.00 |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -2,359.00 |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn | 126,951.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1,267.00 |
| Dec 31, 2024 | 1,283.00 |
| Sep 30, 2024 | 1,139.00 |
| Jun 30, 2024 | 598.00 |
| Mar 31, 2024 | 975.00 |
| Dec 31, 2023 | -4,445.00 |
| Sep 30, 2023 | 198,769.00 |
| Jun 30, 2023 | 93,494.00 |
| Mar 31, 2023 | 253.00 |
| Dec 31, 2022 | -1,012.00 |
| Sep 30, 2022 | -198,933.00 |
| Jun 30, 2022 | -94,253.00 |
| Mar 31, 2022 | -397.00 |
| Dec 31, 2021 | 5,252.00 |
| Sep 30, 2021 | -980.00 |
| Jun 30, 2021 | 1,267.00 |
| Mar 31, 2021 | 678.00 |
| Dec 31, 2020 | 11,227.00 |
| Sep 30, 2020 | 2,067.00 |
| Jun 30, 2020 | 311.00 |